WORLD (Enmaeya News) - November 30, 2025
Prostate cancer is one of the most common cancers among men, affecting 1 in 8 men. The risk of developing the disease increases after the age of 50, particularly for those with a family history or genetic mutations such as BRCA1 and BRCA2, in addition to lifestyle factors like obesity and physical inactivity.
Dr. Amin Abyad, a specialist in oncology and internal medicine, told Sky News Arabia that awareness levels remain low, and early detection through PSA testing and clinical examination can reduce mortality by more than 50%. Multi-parametric MRI (mpMRI) has also contributed to more accurate diagnoses and helped avoid unnecessary biopsies.
Recent years have witnessed significant advancements in treatment, including hormonal therapy and targeted drugs such as PARP inhibitors for patients with specific genetic mutations, PSMA radioligand therapy for advanced prostate cancers, and robotic surgery, which minimizes bleeding and complications while preserving sensitive nerves.
Furthermore, precision medicine, immunotherapy, artificial intelligence, and liquid biopsies play an increasingly important role in improving diagnosis and selecting the most suitable treatment for each patient.
Dr. Abyad concludes by emphasizing that early detection saves lives, and scientific advancements now provide patients with better chances of recovery and longer life, even in advanced stages.
